GCC Oncology/Cancer Drugs market is anticipated to grow at a considerable CAGR during 2020-25

marknteladvisors.com

GCC Oncology/Cancer Drugs Market Analysis, 2020

Document Outline

Introduction About Us, Key Questions Answered In This Study

Table of Content Market Segmentation, Scope of Work

Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting

Sample Pages GCC Oncology/Cancer Drugs Market Analysis, 2020

02

05

13

21

Commercials

43

Disclaimer

45

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

2

Market Segmentation GCC Oncology/Cancer Drugs Market Segmentation

By Therapy

By Company

By Application

By Region

•

Chemotherapy

•

UAE

•

Breast Cancer

•

Hoffmann-La Roche Ltd.

•

Immunotherapy

•

Saudi Arabia

•

Lung Cancer

•

Johnson & Johnson Middle

•

Targeted Therapy

•

Oman

•

Kidney Cancer

•

Radiation

•

Bahrain

•

Liver cancer

•

Surgical

•

Kuwait

•

Ovarian Cancer

•

Others

•

Qatar

•

Prostate Cancer

•

Skin Cancer

•

Pancreatic Cancer

•

Colorectal Cancer

•

Blood Cancer

•

AstraZeneca Gulf FZ LLC

•

Others

•

Bayer Middle East FZE

•

Amgen Inc.

•

Astellas MENA/SSA

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

East FZ LLC •

Pfizer International

Corporation •

Merck Serono Middle East FZLtd.

•

AbbVie Biopharmaceuticals GmbH

3

Historical Year: 2015 Base Year: 2019

Table of Content (1/6)

Forecast Year: 2025 Table of Content

1.

Introduction 1.1.

Product Definition

1.2.

Research Process

1.3.

Market Segmentation

1.4.

Assumptions

2.

Executive Summary

3.

GCC Market Overview

4.

Impact of COVID-19 on GCC Oncology/Cancer Drugs Market

5.

Expert Verbatim-Interview Excerpts of industry experts

6.

GCC Oncology/Cancer Drugs Market Outlook, 2015-2025 6.1.

Market Size & Analysis 6.1.1. Revenues

6.2.

Market Share & Analysis 6.2.1. By Therapy 6.2.1.1. Chemotherapy

6.2.1.2. Immunotherapy 6.2.1.3. Targeted Therapy 6.2.1.4. Radiation 6.2.1.5. Surgical 6.2.1.6. Others Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

4

Historical Year: 2015 Base Year: 2019

Table of Content (2/6)

Forecast Year: 2025 Table of Content

6.2.2. By Application 6.2.2.1. Breast Cancer 6.2.2.2. Lung Cancer 6.2.2.3. Kidney Cancer 6.2.2.4. Liver cancer 6.2.2.5. Ovarian Cancer

6.2.2.6. Prostate Cancer 6.2.2.7. Skin Cancer 6.2.2.8. Pancreatic Cancer 6.2.2.9. Colorectal Cancer 6.2.2.10. Blood Cancer 6.2.2.11. Others 6.2.3. By Region 6.2.3.1. UAE 6.2.3.2. Saudi Arabia

6.2.3.3. Oman 6.2.3.4. Bahrain 6.2.3.5. Kuwait 6.2.3.6. Qatar 6.2.4. By Company Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

5

Historical Year: 2015 Base Year: 2019

Table of Content (3/6)

Forecast Year: 2025 Table of Content

6.2.4.1. Market Shares, By Revenue 6.2.4.2. Strategic Factorial Indexing 6.2.4.3. Competitor Placement in MarkNtel Quadrant 6.3.

Market Attractiveness Index 6.3.1. By Therapy 6.3.2. By Application

6.3.3. By Region 7.

UAE Oncology/Cancer Drugs Market Outlook, 2015-2025 7.1.

Market Size & Analysis 7.1.1. Revenues

7.2.

Market Share & Analysis 7.2.1. By Therapy 7.2.2. By Application

8.

Saudi Arabia Oncology/Cancer Drugs Market Outlook, 2015-2025 8.1.

Market Size & Analysis

8.1.1. Revenues 8.2.

Market Share & Analysis 8.2.1. By Therapy 8.2.2. By Application

9.

Oman Oncology/Cancer Drugs Market Outlook, 2015-2025 Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

6

Historical Year: 2015 Base Year: 2019

Table of Content (4/6)

Forecast Year: 2025 Table of Content

9.1.

Market Size & Analysis 9.1.1. Revenues

9.2.

Market Share & Analysis 9.2.1. By Therapy 9.2.2. By Application

10. Bahrain Oncology/Cancer Drugs Market Outlook, 2015-2025

10.1. Market Size & Analysis 10.1.1. Revenues 10.2. Market Share & Analysis 10.2.1. By Therapy 10.2.2. By Application 11. Kuwait Oncology/Cancer Drugs Market Outlook, 2015-2025 11.1. Market Size & Analysis 11.1.1. Revenues 11.2. Market Share & Analysis

11.2.1. By Therapy 11.2.2. By Application 12. Qatar Oncology/Cancer Drugs Market Outlook, 2015-2025 12.1. Market Size & Analysis 12.1.1. Revenues Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

7

Historical Year: 2015 Base Year: 2019

Table of Content (5/6)

Forecast Year: 2025 Table of Content

12.2. Market Share & Analysis 12.2.1. By Therapy 12.2.2. By Application 13. GCC Oncology/Cancer Drugs Market Policies, Regulations, Product Standards

14. GCC Oncology/Cancer Drugs Market Trends & Insights 15. GCC Oncology/Cancer Drugs Market Dynamics 15.1. Growth Drivers 15.2. Challenges 15.3. Impact Analysis 16. GCC Oncology/Cancer Drugs Market Hotspot & Opportunities

17. GCC Oncology/Cancer Drugs Market Key Strategic Imperatives for Success & Growth 18. Competition Outlook 18.1. Competition Matrix 18.1.1. Product Portfolio 18.1.2. Target Markets 18.1.3. Research & Development

18.1.4. Strategic Alliances 18.1.5. Strategic Initiatives

18.2. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans) 18.2.1. Hoffmann-La Roche Ltd. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

8

Historical Year: 2015 Base Year: 2019

Table of Content (6/6)

Forecast Year: 2025 Table of Content

18.2.2. Johnson & Johnson Middle East FZ LLC 18.2.3. Pfizer International Corporation 18.2.4. Merck Serono Middle East FZ-Ltd. 18.2.5. AbbVie Biopharmaceuticals GmbH 18.2.6. AstraZeneca Gulf FZ LLC 18.2.7. Bayer Middle East FZE

18.2.8. Amgen, Inc. 18.2.9. Astellas MENA/SSA 19. Disclaimer

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

9

Document Outline

Introduction About Us, Key Questions Answered In This Study

Table of Content Market Segmentation, Scope Of Work

Research Process & Methodology Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research Methodology, Forecasting

Sample Pages GCC Oncology/Cancer Drugs Market Analysis, 2020

02

05

13

21

Commercials

43

Disclaimer

45

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

10

GCC Oncology/Cancer Drugs Market Outlook, 2015-2025F

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

GCC Oncology/Cancer Drugs Market Outlook, By Revenues Figure XX: GCC Oncology/Cancer Drugs Market Revenues (USD Million), 2015 - 2025F

2015

2016

2017

Revenue: XX%

CAGR

CAGR

Revenue: XX%

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Source: MarkNtel Advisors

• The GCC oncology/cancer drugs market is augmenting over the past couple of years. The availability of generic drugs, reimbursement policy, and rising tobacco smoking are the main factors that contributed to the growth of the market. Tobacco smoking is a key reason for diagnosed lung, urinary bladder, and colorectal cancer among male individuals in GCC. With the surging number of such cancer patients in the region, the demand for cancer drugs is flourishing through 2015.

• The outbreak of COVID-19 has generated a situation of lockdown and overburden of patients in healthcare settings. Due to this reason, the

low-risk cancer procedures and diagnostic tests of cancer were suspended, which leads to lesser number of new cancer patients diagnosed in early 2020 in the gulf countries. However, with the marginalizing impact of COVID-19, the demand for cancer drugs is set to proliferate during the forecast period.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

12

GCC Oncology/Cancer Drugs Market Size, By Therapy Figure XX: GCC Oncology/Cancer Drugs Market Size (USD Million), By Therapy, 2019 & 2025F

2019

2025F

Chemotherapy

Chemotherapy

Surgical

Surgical

Radiation

Radiation

Targeted Therapy

Targeted Therapy

Immunotherapy

Immunotherapy

Others

Others *These are dummy charts and do not represent actual value

Source: MarkNtel Advisors

• Targeted Therapy: The growing adoption of advanced therapies for the treatment of cancer amid end-users in the region has been generating the demand for targeted drugs over the last few years. Furthermore, the increasing demand for combination therapy for cancer treatment also driving the additional sales of targeted drugs since 2015. For instance: use of targeted therapy with chemotherapy, targeted therapy with immunotherapy, etc. These are among few of the key factors that contributed to the positive growth of the targeted therapy segment in the Gulf region.

• Breast, lung, and colorectal cancer are majorly diagnosed in the population of GCC, and targeted therapy is widely used for the treatment of such cancers over the past couple of years. The mushrooming cases of such cancers in the region vaticinated to propel the utilization of targeted therapy. Thus, the market revenue of the targeted therapy segment would flourish by 2025.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

13

GCC Oncology/Cancer Drugs Market Revenue Share, By Application Figure XX: GCC Oncology/Cancer Drugs Market Revenue Share (%), By Application, 2019 & 2025F Breast Cancer Lung Cancer Kidney Cancer Liver cancer Ovarian Cancer Prostate Cancer Skin Cancer Pancreatic Cancer Colorectal Cancer Blood Cancer Others

2019

*These are dummy charts and do not represent actual value

2025F

Source: MarkNtel Advisors

• Breast Cancer: This is among the prime segment that supports the GCC oncology/cancer drugs market to grow over the past few years.

Breast cancer is the most common cancer diagnosed among women aged less than 50 years in the region due to overweight. The increasing prevalence of overweight has been surging the risk of developing breast cancer among women, thus anticipated that the demand for oncology drugs would increase during 2020-25.

• The growing awareness about early diagnosis among individuals expected to surge the number of breast cancer patients in the gulf

countries. Moreover, the increasing pharmaceutical companies' focus to launch new drugs for effective treatment of breast cancer has been soaring the drug pipeline. Hence, the market share of the segment would escalate by 2025.

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

14

GCC Oncology/Cancer Drugs Market Revenue Share, By Region Figure XX: GCC Oncology/Cancer Drugs Market Revenue Share (%), By Region, 2019 & 2025F

Kuwait Bahrain Saudi Arabia

Country

2019

2025F

CAGR (2020-25)

UAE

XX%

XX%

XX%

Saudi Arabia

XX%

XX%

XX%

Oman

XX%

XX%

XX%

Qatar

XX%

XX%

XX%

Kuwait

XX%

XX%

XX%

Bahrain

XX%

XX%

XX%

Qatar UAE Oman

Source: MarkNtel Advisors

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

15

UAE Oncology/Cancer Drugs Market Outlook, By Revenues Figure XX: UAE Oncology/Cancer Drugs Market Revenues (USD Million), 2015 - 2025F

2015

2016

2017

Revenue: XX%

CAGR

CAGR

Revenue: XX%

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Source: MarkNtel Advisors

• The UAE oncology/cancer drugs market dominated the GCC market over the past few years. The UAE market has foreseen a positive growth due to initiatives taken by the government and organizations. The country’s healthcare expenditure is set to grow at a aCAGR of around 5% during 2020-25. In addition, the government sponsored cancer research programs in collaboration with foreign research centers is set to have a positive impact on cancer drugs market. The Emirates Oncology Society (EOS) collaborated with AstraZeneca in 2020 for generating awareness among individuals and mass screening of cancer to decline the mortality rate of cancer by 18% by 2021.

The patients diagnosed with cancer is anticipated to escalate and would add more demand for oncology cancer in the coming years.

• In addition, several non profit organization are also playing an anchor role in creating awareness about cancer among individuals in UAE. For instance: Friends of Cancer Patients (FOCP), a non-profit organization has launched Ramadan Zakat Campaign “I Deserve a Life” in Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

16

+1 (613) 707-5086 sales@marknteladvisors.com

Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.

17